Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+ in Chinese Critically Ill Patients: a Prospective Randomized Controlled Clinical Trial

NCT07326215 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.

NCT NCT07326215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07326215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+ in Chinese Critically Ill Patients: a Prospective Randomized Controlled Clinical Trial
Lead sponsor
Vantive Health LLC
Phase
Not applicable
Overall status
Recruiting
Start date
December 11, 2025
Completion date
February 28, 2027
Enrollment
99 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, acute respiratory distress syndrome